報道指深圳料年內將有包括「在港上市的大灣區企業回深交所上市」等一系列改革落地
內媒《證券時報》旗下《人民財訊》報道,自《關於深入推進深圳綜合改革試點深化改革創新擴大開放的意見》印發以來,深圳相關部門加強與中央部委的溝通,同時全面梳理相關上市的粵港澳大灣區企業情況,充分了解企業的相關訴求。
目前,主管部門已與中證監相關司局就資本市場支持深圳綜合改革建立了常態化溝通機制,預計年內將有包括港交所(00388.HK)上市的粵港澳大灣區企業按照政策規定回深圳證券交易所上市等一系列改革成果落地。後續,還將積極調研、廣泛收集企業訴求,繼續抓好優質上市後備資源培育,深化資本市場協同合作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.